Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MILLIKAN, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MILLIKAN, C. H.

(Stroke. 1971;2:201.)
© 1971 American Heart Association, Inc.


Reassessment of Anticoagulant Therapy in Various Types of Occlusive Cerebrovascular Disease

CLARK H. MILLIKAN M.D.1

1 Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, 55901

Precise use of categorical terms and definitions is mandatory in discussing the use of anticoagulants in treating occlusive cerebrovascular disease. The components of the temporal profile of the disease are described.

Six reports have appeared which describe the results of anticagulant therapy in transient cerebral ischemic attacks. From these six studies it is concluded that anticoagulant therapy significantly decreased the risk of cerebral infarction in patients who had attacks of transient focal cerebral ischemia.

In the few carefully performed investigations of the use of anticoagulant for acute progressing stroke the evidence points to the lack of progression in patients receiving treatment when compared to individuals not getting such drugs.

There continues to be a definite difference of opinion about the results of anticoagulant therapy in completed stroke. If anticoagulant is to be administered on a long-term basis, it must be considered dangerous and every effort made to control the level of anticoagulant action precisely. Hypertension must be effectively controlled.


Key Words: progressing stroke • completed stroke • transient ischemic attacks • cerebral infarction • hypertension




This article has been cited by other articles:


Home page
Arch NeurolHome page
S. F. Putman and H. P. Adams Jr
Usefulness of Heparin in Initial Management of Patients With Recent Transient Ischemic Attacks
Arch Neurol, October 1, 1985; 42(10): 960 - 962.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. I. Sage
Stroke: The Use and Overuse of Heparin in Therapeutic Trials
Arch Neurol, April 1, 1985; 42(4): 315 - 317.
[Abstract] [PDF]


Home page
Arch SurgHome page
M. L. Owens and S. E. Wilson
Prevention of Neurologic Complications of Carotid Endarterectomy
Arch Surg, May 1, 1982; 117(5): 551 - 555.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. F. Toole and G. Howard
Physician Attitudes: Management of Asymptomatic Carotid Artery Murmur and Transient Ischemic Attacks
Arch Neurol, July 1, 1981; 38(7): 443 - 446.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. A. Obeso, J. F. Marti-Masso, N. Carrera, and W. Astudillo
Pure Motor Quadriplegia Secondary to Bilateral Capsular Hematomas
Arch Neurol, April 1, 1980; 37(4): 248 - 248.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
R.H. Clauss and W. Redisch
The Relative Roles of Medicine and Surgery in the Manage ment of Occlusive Arterial Disease
Angiology, February 1, 1975; 26(2): 233 - 234.
[PDF]